146 related articles for article (PubMed ID: 23389386)
1. Thrombolysis in ischemic stroke patients on treatment with Dabigatran.
Re G; Toni D
Intern Emerg Med; 2013 Aug; 8(5):451-2. PubMed ID: 23389386
[No Abstract] [Full Text] [Related]
2. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
[TBL] [Abstract][Full Text] [Related]
3. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
Zotova IV; Zateĭshchikov DA
Kardiologiia; 2014; 54(2):79-85. PubMed ID: 24888206
[No Abstract] [Full Text] [Related]
4. Stroke thrombolysis in patients taking dabigatran.
Jayathissa S; Gommans J; Harper P
Intern Med J; 2013 Jul; 43(7):826-8. PubMed ID: 23841763
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran - neurosurgical anathema?
Thomas PA; Schaerf NB; Rosenfeld JV
Med J Aust; 2013 Aug; 199(4):238-40. PubMed ID: 23984772
[No Abstract] [Full Text] [Related]
6. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
Rybinnik I; Mullen MT; Messe S; Kasner SE; Cucchiara B
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1312-6. PubMed ID: 23313461
[TBL] [Abstract][Full Text] [Related]
7. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
Diogo C; Duarte J; Sobral S; Pestana P; Nzwalo H; Rita H; Sousa E Costa J
Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
[TBL] [Abstract][Full Text] [Related]
8. Reversible Cognitive Impairment Associated with the Use of Dabigatran.
La Brooy B; Ho P; Lim K
J Am Geriatr Soc; 2015 Aug; 63(8):1717-9. PubMed ID: 26289705
[No Abstract] [Full Text] [Related]
9. Coronary embolization following electrical cardioversion in a patient treated with dabigatran.
Gagliardi L; Guerbaai RA; Marlière S; Bouvaist H; Ennezat PV
Int J Cardiol; 2014 Aug; 175(3):571-2. PubMed ID: 24861253
[No Abstract] [Full Text] [Related]
10. Using dabigatran in patients with stroke: a practical guide for clinicians.
Alberts MJ; Bernstein RA; Naccarelli GV; Garcia DA
Stroke; 2012 Jan; 43(1):271-9. PubMed ID: 22156688
[No Abstract] [Full Text] [Related]
11. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
Matute MC; Guillán M; García-Caldentey J; Buisan J; Aparicio M; Masjuan J; Alonso de Leciñana M
Thromb Haemost; 2011 Jul; 106(1):178-9. PubMed ID: 21505718
[No Abstract] [Full Text] [Related]
12. Dabigatran: will it change clinical practice?
Wartak SA; Bartholomew JR
Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal bleeding associated with dabigatran in a patient with panhypopituitarism.
Gunes F; Asik M; Temiz A; Binnetoglu E; Sen H; Bilen Oİ; Akbal E; Adam G; Ukinc K
Wien Klin Wochenschr; 2014 Jan; 126(1-2):62-3. PubMed ID: 24240609
[No Abstract] [Full Text] [Related]
14. Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
Stöllberger C; Rakusan S; Wimpissinger FT; Finsterer J
Thromb Haemost; 2012 Sep; 108(3):579-81. PubMed ID: 22739630
[No Abstract] [Full Text] [Related]
15. Diffuse alveolar hemorrhage associated with dabigatran.
Yokoi K; Isoda K; Kimura T; Adachi T
Intern Med; 2012; 51(18):2667-8. PubMed ID: 22989848
[No Abstract] [Full Text] [Related]
16. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
Kono S; Deguchi K; Omote Y; Yunoki T; Yamashita T; Kurata T; Ikeda Y; Abe K
J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
[TBL] [Abstract][Full Text] [Related]
17. [Advantages of NOAKs validated in clinical routine].
Ameri AA
MMW Fortschr Med; 2015 May; 157(9):70. PubMed ID: 26012835
[No Abstract] [Full Text] [Related]
18. What is the role of renal replacement therapy in the setting of dabigatran toxicity?
Ghannoum M; Nolin TD
Semin Dial; 2014; 27(3):223-6. PubMed ID: 24620942
[No Abstract] [Full Text] [Related]
19. [Extensive thromboembolism after cardioversion in a patient treated with dabigatran].
Buch TN; Holm J; Munck LK
Ugeskr Laeger; 2013 Feb; 175(6):333-4. PubMed ID: 23402235
[TBL] [Abstract][Full Text] [Related]
20. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
Eikelboom JW; Connolly SJ; Hart RG; Wallentin L; Reilly P; Oldgren J; Yang S; Yusuf S
J Am Coll Cardiol; 2013 Sep; 62(10):900-8. PubMed ID: 23770182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
